Replies to post #75562 on Biotech Values

[DewDiligence]

GILD sues TEVA on Atripla P-IV challenge:

http://finance.yahoo.com/news/Gilead-Sciences-Files-Second-bw-15249228.html

Inasmuch as Truvada is a component of Atripla, for all practical purposes this is the same lawsuit on the one stemming from Teva’s P-IV challenge against Truvada (#msg-34164531).